News
-
-
-
PRESS RELEASE
Abivax announces presentation of four abstracts for obefazimod in ulcerative colitis and sponsorship of scientific symposium at the 19th Congress of European Crohn’s and Colitis Organization (ECCO)
Abivax to present four abstracts on obefazimod for ulcerative colitis at 19th ECCO Congress, including a sponsored symposium on emerging treatment mechanisms. Event details available on ECCO website -
PRESS RELEASE
Abivax annonce la présentation de quatre abstracts sur obefazimod dans la rectocolite hémorragique et l’organisation d’un symposium scientifique au 19e congrès de la ECCO
Abivax annonce la présentation de quatre abstracts sur obefazimod dans la rectocolite hémorragique et l'organisation d'un symposium scientifique au 19e congrès de la ECCO. Pour plus d'informations, visitez le stand Abivax dans le hall des exposants de l’ECCO -
-
REGULATED PRESS RELEASE
Cie du Bois Sauvage: Buy back of own shares – week from 05/02/2024 to 09/02/2024
Cie du Bois Sauvage announces buy back of own shares from 05/02/2024 to 09/02/2024 in line with authorization from 2021. Details of transactions disclosed including number of shares and total amount -
-
-
-